{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:34:32Z","timestamp":1782866072745,"version":"3.54.5"},"reference-count":37,"publisher":"King Faisal Specialist Hospital and Research Centre","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Saudi Med"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND:<\/jats:title>\n            <jats:p>Acute respiratory distress syndrome (ARDS), which results in lung injury as a consequence of sepsis and septic shock, is associated with severe systemic inflammation and is responsible for a high worldwide mortality rate.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>Investigate whether corticosteroids could benefit clinical outcomes in adult with ARDS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>A comprehensive search of electronic databases Ovid MEDLINE, Ovid EMbase, and Cochrane Library from their inception to 7 May 2023 was conducted to identify studies that met the eligibility criteria, including only randomized controlled trials. The study was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and the methods of trial sequential analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MAIN OUTCOME MEASURES:<\/jats:title>\n            <jats:p>Mortality rates, including including the 14-, 28-, 45-, and 60-day mortality, hospital mortality, and intensive care unit (ICU) mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SAMPLE SIZE:<\/jats:title>\n            <jats:p>17 studies with 2508 patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Data relating to mortality at 14, 28, 45, and 60 days were not significantly different when treatments with corticosteroids and placebo were compared. In terms of hospital and ICU mortality, the mortality of those who had received corticosteroids was significantly lower than that of those who had not. ARDS patients who received assisted ventilation benefited from corticosteroid therapy, as revealed by the significant difference in outcome days between those who received assisted ventilation and those who did not. Corticosteroid had significantly more days free from mechanical ventilation, ICU-free days, and MODS-free days during the first 28 days, but not more organ support-free days up to day 28.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>Although corticosteroid therapy did not reduce mortality rates at different observation periods, it significantly reduced hospital and ICU mortality. Administering corticosteroids to ARDS patients significantly decreased the days of assisted ventilation and time cost consumption. This study confirmed that long-term use of low-dose glucocorticoids may have a positive effect on early ARDS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>LIMITATION:<\/jats:title>\n            <jats:p>Risk of bias due to the differences in patient characteristics.<\/jats:p>\n          <\/jats:sec>","DOI":"10.5144\/0256-4947.2024.167","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T06:14:09Z","timestamp":1718000049000},"page":"167-182","source":"Crossref","is-referenced-by-count":7,"title":["Clinical outcomes of corticosteroid administration for acute respiratory distress syndrome in adults based on meta-analyses and trial sequential analysis"],"prefix":"10.5144","volume":"44","author":[{"given":"Di","family":"Wu","sequence":"first","affiliation":[{"name":"From the Department of Pharmacy, Hubei Provincial Hospital of Traditional Chinese Medicine\/Affiliated Hospital of Hubei University of Chinese Medicine, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3685-6604","authenticated-orcid":false,"given":"Yue","family":"Li","sequence":"additional","affiliation":[{"name":"From the Department of Respiratory Medicine, Hubei Provincial Hospital of Traditional Chinese Medicine\/Affiliated Hospital of Hubei University of Chinese Medicine, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Hua","family":"Dong","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacy, Hubei Provincial Hospital of Traditional Chinese Medicine\/Affiliated Hospital of Hubei University of Chinese Medicine, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Gao","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacy, Hubei Provincial Hospital of Traditional Chinese Medicine\/Affiliated Hospital of Hubei University of Chinese Medicine, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3134","reference":[{"issue":"144","key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"160116","DOI":"10.1183\/16000617.0116-2016","article-title":"Acute respiratory distress syndrome","volume":"26","author":"Confalonieri M","year":"2017","unstructured":"Confalonieri M, Salton F, Fabiano F. Acute respiratory distress syndrome. Eur Respir Rev. 2017;26(144):160116.","journal-title":"Eur Respir Rev"},{"issue":"6","key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1056\/NEJMra1608077","article-title":"Acute Respiratory Distress Syndrome","volume":"377","author":"Thompson BT","year":"2017","unstructured":"Thompson BT, Chambers RC, Liu KD. Acute Respiratory Distress Syndrome. N Engl J Med. 2017;377(6):562\u201372.","journal-title":"N Engl J Med"},{"issue":"8","key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/BF02730667","article-title":"Acute lung injury and acute respiratory distress syndrome","volume":"71","author":"Vasudevan A","year":"2004","unstructured":"Vasudevan A, Lodha R, Kabra SK. Acute lung injury and acute respiratory distress syndrome. Indian J Pediatr. 2004;71(8):743\u201350.","journal-title":"Indian J Pediatr"},{"issue":"135","key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1183\/09059180.00012414","article-title":"Recent advances in mechanical ventilation in patients with acute respiratory distress syndrome","volume":"24","author":"Rittayamai N","year":"2015","unstructured":"Rittayamai N, Brochard L. Recent advances in mechanical ventilation in patients with acute respiratory distress syndrome. Eur Respir Rev. 2015;24(135):132\u201340.","journal-title":"Eur Respir Rev"},{"issue":"32109","key":"e_1_3_2_6_2","article-title":"Thromboxane A2 exacerbates acute lung injury via promoting edema formation","volume":"6","author":"Kobayashi K","year":"2016","unstructured":"Kobayashi K, Horikami D, Omori K, Nakamura T, Yamazaki A, Maeda S, et al. Thromboxane A2 exacerbates acute lung injury via promoting edema formation. Sci Rep. 2016;6(32109.","journal-title":"Sci Rep"},{"issue":"14","key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/CLEP.S341048","article-title":"Glucocorticoids and risk of venous thromboembolism in asthma patients aged 20-59 years in the united kingdom's CPRD 1995-2015","volume":"20","author":"Ayodele OA","year":"2022","unstructured":"Ayodele OA, Cabral HJ, McManus DD, Jick SS. Glucocorticoids and risk of venous thromboembolism in asthma patients aged 20-59 years in the united kingdom's CPRD 1995-2015. Clin Epidemiol. 2022;20:14:83\u201393.","journal-title":"Clin Epidemiol"},{"issue":"7651","key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/bmj.39537.939039.BE","article-title":"Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis","volume":"336","author":"Peter JV","year":"2008","unstructured":"Peter JV, John P, Graham PL, Moran JL, George IA, Bersten A. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. Bmj. 2008;336(7651):1006\u20139.","journal-title":"Bmj"},{"issue":"12","key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2169\/internalmedicine.54.4015","article-title":"Impact of Corticosteroids on Mortality in Patients with Acute Respiratory Distress Syndrome: A Systematic Review and Meta-analysis","volume":"54","author":"Horita N","year":"2015","unstructured":"Horita N, Hashimoto S, Miyazawa N, Fujita H, Kojima R, Inoue M, et al. Impact of Corticosteroids on Mortality in Patients with Acute Respiratory Distress Syndrome: A Systematic Review and Meta-analysis. Intern Med. 2015;54(12):1473\u20139.","journal-title":"Intern Med"},{"issue":"1","key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.CCM.0000194723.78632.62","article-title":"Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome","volume":"34","author":"Annane D","year":"2006","unstructured":"Annane D, Sebille V, Bellissant E. Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med. 2006;34(1):22\u201330.","journal-title":"Crit Care Med"},{"issue":"1","key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s13054-016-1511-2","article-title":"Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial","volume":"20","author":"Tongyoo S","year":"2016","unstructured":"Tongyoo S, Permpikul C, Mongkolpun W, Vattanavanit V, Udompanturak S, Kocak M, et al. Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial. Crit Care. 2016;20(1):329.","journal-title":"Crit Care"},{"issue":"6","key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1164\/rccm.201609-1767CI","article-title":"Fifty Years of Research in ARDS. Is Acute Respiratory Distress Syndrome a Preventable Disease?","volume":"195","author":"Yadav H","year":"2017","unstructured":"Yadav H, Thompson BT, Gajic O. Fifty Years of Research in ARDS. Is Acute Respiratory Distress Syndrome a Preventable Disease? Am J Respir Crit Care Med. 2017;195(6):725\u201336.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher D","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Med"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","DOI":"10.1093\/med\/9780199235339.001.0001","volume-title":"Oxford handbook of critical care","author":"Singer M","year":"2009","unstructured":"Singer M. Oxford handbook of critical care, 3rd edn. Oxford: Oxford University Press. 2009;","edition":"3"},{"issue":"5928","key":"e_1_3_2_15_2","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins JP","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. Bmj. 2011;343(d5928.","journal-title":"Bmj"},{"issue":"5","key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jclinepi.2010.09.016","article-title":"Ratio of means for analyzing continuous outcomes in meta-analysis performed as well as mean difference methods","volume":"64","author":"Friedrich J","year":"2011","unstructured":"Friedrich J, Adhikari N, Beyene J. Ratio of means for analyzing continuous outcomes in meta-analysis performed as well as mean difference methods. Journal of clinical epidemiology. 2011;64(5):556\u201364.","journal-title":"Journal of clinical epidemiology"},{"issue":"11","key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins J","year":"2002","unstructured":"Higgins J, Thompson S. Quantifying heterogeneity in a meta-analysis. Statistics in medicine. 2002;21(11):1539\u201358.","journal-title":"Statistics in medicine"},{"key":"e_1_3_2_18_2","first-page":"1","article-title":"User manual for trial sequential analysis (TSA). Copenhagen, Denmark: Copenhagen trial unit","author":"Thorlund k","year":"2011","unstructured":"Thorlund k, Engstrom J, Wetterslev J, Brok J, Imberger G, Gluud C. User manual for trial sequential analysis (TSA). Copenhagen, Denmark: Copenhagen trial unit. Cent Clin Interv Res. 2011;1\u2013115):","journal-title":"Cent Clin Interv Res"},{"issue":"5","key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/archsurg.1985.01390290018003","article-title":"Early steroid therapy for respiratory failure","volume":"120","author":"Weigelt JA","year":"1985","unstructured":"Weigelt JA, Norcross JF, Borman KR, Snyder WH, 3rd. Early steroid therapy for respiratory failure. Arch Surg. 1985;120(5):536\u201340.","journal-title":"Arch Surg"},{"issue":"16","key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa051693","article-title":"Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome","volume":"354","author":"Steinberg KP","year":"2006","unstructured":"Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006;354(16):1671\u201384.","journal-title":"N Engl J Med"},{"issue":"6","key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1378\/chest.91.6.850","article-title":"Complement activation and corticosteroid therapy in the development of the adult respiratory distress syndrome","volume":"91","author":"Schein RM","year":"1987","unstructured":"Schein RM, Bergman R, Marcial EH, Schultz D, Duncan RC, Arnold PI, et al. Complement activation and corticosteroid therapy in the development of the adult respiratory distress syndrome. Chest. 1987;91(6):850\u20134.","journal-title":"Chest"},{"issue":"7","key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1164\/ajrccm.165.7.2106014","article-title":"Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids","volume":"165","author":"Meduri GU","year":"2002","unstructured":"Meduri GU, Tolley EA, Chrousos GP, Stentz F. Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am J Respir Crit Care Med. 2002;165(7):983\u201391.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jama.280.2.159","article-title":"Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial","volume":"280","author":"Meduri GU","year":"1998","unstructured":"Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. Jama. 1998;280(2):159\u201365.","journal-title":"Jama"},{"issue":"4","key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1378\/chest.06-2100","article-title":"Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial","volume":"131","author":"Meduri GU","year":"2007","unstructured":"Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest. 2007;131(4):954\u201363.","journal-title":"Chest"},{"issue":"6","key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/CCM.0000000000003021","article-title":"An Exploratory Reanalysis of the Randomized Trial on Efficacy of Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome","volume":"46","author":"Meduri GU","year":"2018","unstructured":"Meduri GU, Bridges L, Siemieniuk RAC, Kocak M. An Exploratory Reanalysis of the Randomized Trial on Efficacy of Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome. Crit Care Med. 2018;46(6):884\u201391.","journal-title":"Crit Care Med"},{"issue":"6","key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1378\/chest.92.6.1032","article-title":"Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome","volume":"92","author":"Bone RC","year":"1987","unstructured":"Bone RC, Fisher CJ, Jr., Clemmer TP, Slotman GJ, Metz CA. Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest. 1987;92(6):1032\u20136.","journal-title":"Chest"},{"issue":"25","key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM198712173172504","article-title":"Highdose corticosteroids in patients with the adult respiratory distress syndrome","volume":"317","author":"Bernard GR","year":"1987","unstructured":"Bernard GR, Luce JM, Sprung CL, Rinaldo JE, Tate RM, Sibbald WJ, et al. Highdose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med. 1987;317(25):1565\u201370.","journal-title":"N Engl J Med"},{"issue":"2","key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/CCM.0b013e318232da5e","article-title":"Effects of methylprednisolone infusion on markers of inflammation, coagulation, and angiogenesis in early acute respiratory distress syndrome","volume":"40","author":"Seam N","year":"2012","unstructured":"Seam N, Meduri GU, Wang H, Nylen ES, Sun J, Schultz MJ, et al. Effects of methylprednisolone infusion on markers of inflammation, coagulation, and angiogenesis in early acute respiratory distress syndrome. Crit Care Med. 2012;40(2):495\u2013501.","journal-title":"Crit Care Med"},{"issue":"3","key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","article-title":"Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial","volume":"8","author":"Villar J","year":"2020","unstructured":"Villar J, Ferrando C, Martinez D, Ambros A, Munoz T, Soler JA, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020;8(3):267\u201376.","journal-title":"Lancet Respir Med"},{"issue":"13","key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.2020.17021","article-title":"Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial","volume":"324","author":"Tomazini BM","year":"2020","unstructured":"Tomazini BM, Maia IS, Cavalcanti AB, Berwanger O, Rosa RG, Veiga VC, et al. Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial. Jama. 2020;324(13):1307\u201316.","journal-title":"Jama"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejcdt.2013.02.013","article-title":"Effects of methyl prednisolone in early ARDS","volume":"62","author":"Rezk NA","year":"2013","unstructured":"Rezk NA, Ibrahim AM. Effects of methyl prednisolone in early ARDS. Egyptian Journal of Chest Diseases and Tuberculosis. 2013;62:167\u201372.","journal-title":"Egyptian Journal of Chest Diseases and Tuberculosis"},{"issue":"13","key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.2020.17022","article-title":"Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial","volume":"324","author":"Angus DC","year":"2020","unstructured":"Angus DC, Derde L, Al-Beidh F, Annane D, Arabi Y, Beane A, et al. Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. Jama. 2020;324(13):1317\u201329.","journal-title":"Jama"},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"173947","DOI":"10.1016\/j.ejphar.2021.173947","article-title":"No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial","volume":"897","author":"Jamaati H","year":"2021","unstructured":"Jamaati H, Hashemian SM, Farzanegan B, Malekmohammad M, Tabarsi P, Marjani M, et al. No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial. European journal of pharmacology. 2021;897:173947.","journal-title":"European journal of pharmacology"},{"issue":"3","key":"e_1_3_2_34_2","first-page":"653","article-title":"Effect of paracetamol on melanization process in human epidermal melanocytes","volume":"73","author":"Wrze.niok D","year":"2016","unstructured":"Wrze.niok D, Oprzondek M, Hechmann A, Beberok A, Otreba M, Buszman E. Effect of paracetamol on melanization process in human epidermal melanocytes. Acta Pol Pharm. 2016;73(3):653\u20138.","journal-title":"Acta Pol Pharm"},{"issue":"11","key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/14728222.2019.1692816","article-title":"Microvesicles as new therapeutic targets for the treatment of the acute respiratory distress syndrome (ARDS)","volume":"23","author":"Soni S","year":"2019","unstructured":"Soni S, Tirlapur N, O'Dea KP, Takata M, Wilson MR. Microvesicles as new therapeutic targets for the treatment of the acute respiratory distress syndrome (ARDS). Expert Opin Ther Targets. 2019;23(11):931\u201341.","journal-title":"Expert Opin Ther Targets"},{"issue":"4","key":"e_1_3_2_36_2","first-page":"276","article-title":"Corticosteroids for patients with acute respiratory distress syndrome: a systematic review and meta-analysis of randomized trials","volume":"130","author":"Mammen MJ","year":"2020","unstructured":"Mammen MJ, Aryal K, Alhazzani W, Alexander PE. Corticosteroids for patients with acute respiratory distress syndrome: a systematic review and meta-analysis of randomized trials. Pol Arch Intern Med. 2020;130(4):276\u201386.","journal-title":"Pol Arch Intern Med"},{"issue":"1","key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13054-021-03546-0","article-title":"Decreased mortality in acute respiratory distress syndrome patients treated with corticosteroids: an updated meta-analysis of randomized clinical trials with trial sequential analysis","volume":"25","author":"Lin P","year":"2021","unstructured":"Lin P, Zhao Y, Li X, Jiang F, Liang Z. Decreased mortality in acute respiratory distress syndrome patients treated with corticosteroids: an updated meta-analysis of randomized clinical trials with trial sequential analysis. Crit Care. 2021;25(1):122.","journal-title":"Crit Care"},{"key":"e_1_3_2_38_2","unstructured":"Zhao W Wan S-x Gu D Shi BJMJoCPs-LA. Therapeutic effect of glucocorticoid inhalation for pulmonary fibrosis in ARDS patients. 2014;39(741\u20135)."}],"container-title":["Annals of Saudi Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T05:15:11Z","timestamp":1719206111000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.annsaudimed.net\/doi\/10.5144\/0256-4947.2024.167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.5144\/0256-4947.2024.167"],"URL":"https:\/\/doi.org\/10.5144\/0256-4947.2024.167","relation":{},"ISSN":["0256-4947","0975-4466"],"issn-type":[{"value":"0256-4947","type":"print"},{"value":"0975-4466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5]]}}}